BioDelivery Says FDA Doesn't Approve Drug (AP via Yahoo! Finance)
Shares of biopharmaceutical company BioDelivery Sciences International Inc. plunged in aftermarket trading, following a company announcement that it did not receive Food and Drug Administration approval for a proposed drug.